title: Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D001241:Aspirin / Q000191:economics / Q000627:therapeutic use*; D003113:Colonoscopy / Q000191:economics; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D006801:Humans; D008390:Markov Chains; D008403:Mass Screening / Q000191:economics*; D009780:Occult Blood; D012812:Sigmoidoscopy / Q000191:economics
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin